Oncology - European Medical Journal

Continue

Oncology

Filter
24 Jul 2020

Is Immunotherapy Safe for COVID-19 Patients?

COMORBID COVID-19 and cancer is complicated by immunotherapy treatment, which activates an immune system response that may already be overactive
AACR Virtual Annual Meeting II
8 Jun 2020

AACR Virtual Annual Meeting II

The AACR is dedicated to the rapid dissemination of innovative cancer research that has always been the hallmark of our Annual Meetings…
Cancer Care Seeing Dramatic Changes in Light of COVID-19
26 Apr 2020

Cancer Care Seeing Dramatic Changes in Light of COVID-19

SIGNIFICANT changes in cancer care are occurring and expected to continue for the duration of the COVID-19 pandemic, a message delivered in a recently…
Age and sex
26 Apr 2020

Age and Sex Shown to Not Influence Overall Survival in Metastatic Renal Cell Carcinoma

PATIENT counselling is more important than ever for those with cancer, especially considering the burgeoning number of treatments available…
AACR Virtual Annual Meeting I
23 Apr 2020

AACR Virtual Annual Meeting I

The AACR Virtual Annual Meeting I will take place April 27-28. This meeting, which will be the first of two virtual meetings, is FREE and will feature an…
Fluorescence Imaging Agent Used to Improve Lung Cancer Cell Analysis
4 Feb 2020

Fluorescence Imaging Agent Used to Improve Lung Cancer Cell Analysis

A TUMOUR-HIGHLIGHTING agent has been used to aid cardiothoracic surgeons’ visualisation of lung cancer tissue. This is…
Epigenetic Silencing of a Circular RNA Stifles Melanoma Metastasis
4 Feb 2020

Epigenetic Silencing of a Circular RNA Stifles Melanoma Metastasis

ACCOUNTING for 90% of cancer-related deaths, metastasis represents a significant challenge to researchers across the oncological field…
Iron-Doped Copper Nanoparticles Shown to Strengthen Immunotherapy Regimen
4 Feb 2020

Iron-Doped Copper Nanoparticles Shown to Strengthen Immunotherapy Regimen

A MULTIDISCIPLINARY team of scientists have successfully demonstrated tumours in mice to be sensitive to a combination approach of immunotherapy…
We’ve noticed you’re accessing
from North/South America.